The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
Machine Learning Methods in Drug Discovery
Open accessAbstract
The advancements of information technology and related processing techniques have created a fertile base for progress in many scientific fields and industries. In the fields of drug discovery and development, machine learning techniques have been used for the development of novel drug candidates. The methods for designing drug targets and novel drug discovery now routinely combine machine learning and deep learning algorithms to enhance the efficiency, efficacy, and quality of developed outputs. The generation and incorporation of big data, through technologies such as high-throughput screening and high through-put computational analysis of databases used for both lead and target discovery, has increased the reliability of the machine learning and deep learning incorporated techniques. The use of these virtual screening and encompassing online information has also been highlighted in developing lead synthesis pathways. In this review, machine learning and deep learning algorithms utilized in drug discovery and associated techniques will be discussed. The applications that produce promising results and methods will be reviewed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Within the artificial intelligence (AI) discipline, ML methods are considered the most promising techniques for working with unstructured data.”
From Machine learning computational tools to assist the performance of systematic reviews: A mapping review. (2022) · cites this paper as [50]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Breiman, L. (2001) · Machine Learning · doi:10.1023/a:1010933404324 · Cited by 133,538
LeCun, Y., Bengio, Y., & Hinton, G. (2015) · Nature · doi:10.1038/nature14539 · Cited by 84,126
Cortes, C., & Vapnik, V. (1995) · Machine Learning · doi:10.1007/bf00994018 · Cited by 59,421
(2014) · Cited by 33,419
Random Forest: A Classification and Regression Tool for Compound Classification and QSAR Modeling
Svetnik, V., Liaw, A., Tong, C., Culberson, J. C., Sheridan, R. P., & Feuston, B. P. (2003) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci034160g · Cited by 3,573
Encyclopedia of Machine Learning
(2010) · Springer eBooks · doi:10.1007/978-0-387-30164-8 · Cited by 3,465
Applications of machine learning in drug discovery and development
Vamathevan, J., Clark, D., Czodrowski, P., Dunham, I., Ferran, E., Lee, G., Li, B., Madabhushi, A., Shah, P., Spitzer, M., et al. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0024-5 · Cited by 3,228
A Deep Learning Approach to Antibiotic Discovery
Stokes, J. M., Yang, K., Swanson, K., Jin, W., Cubillos-Ruiz, A., Donghia, N. M., MacNair, C. R., French, S., Carfrae, L. A., Bloom-Ackermann, Z., et al. (2020) · Cell · doi:10.1016/j.cell.2020.01.021 · Cited by 2,463
Opportunities and obstacles for deep learning in biology and medicine
Ching, T., Himmelstein, D. S., Beaulieu-Jones, B. K., Kalinin, A. A., Do, B. T., Way, G. P., Ferrero, E., Agapow, P.-M., Zietz, M., Hoffman, M. M., et al. (2018) · Journal of The Royal Society Interface · doi:10.1098/rsif.2017.0387 · Cited by 2,310
Planning chemical syntheses with deep neural networks and symbolic AI
Segler, M. H. S., Preuss, M., & Waller, M. P. (2018) · Nature · doi:10.1038/nature25978 · Cited by 1,847
Cited by
Visan, A. I., & Negut, I. (2024) · Life · doi:10.3390/life14020233 · Cited by 279
Machine learning for perturbational single-cell omics
Ji, Y., Lotfollahi, M., Wolf, F. A., & Theis, F. J. (2021) · Cell Systems · doi:10.1016/j.cels.2021.05.016 · Cited by 137
Advancing pharmaceutical research: A comprehensive review of cutting-edge tools and technologies
Chen, J., Lin, A., & Luo, P. (2024) · Current Pharmaceutical Analysis · doi:10.1016/j.cpan.2024.11.001 · Cited by 112
Schleinitz, J., Langevin, M., Smail, Y., Wehnert, B., Grimaud, L., & Vuilleumier, R. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.2c05302 · Cited by 88
Cierco Jimenez, R., Lee, T., Rosillo, N., Cordova, R., Cree, I. A., Gonzalez, A., & Indave Ruiz, B. I. (2022) · BMC Medical Research Methodology · doi:10.1186/s12874-022-01805-4 · Cited by 85
Metadata
- Authors
- Patel, L., Shukla, T., Huang, X., Ussery, D. W., & Wang, S.
- Affiliations
- University of Arkansas at Little Rock (US)
- Arkansas State University (US)
- University of Arkansas for Medical Sciences (US)
- Corresponding author
- Wang, Shanzhi
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2020-11-12
- Volume
- 25
- Issue
- 22
- Pages
- 5277
- ISSN
- 1420-3049 (ISSN-L)
- PMC
- PMC7696134
- OpenAlex
- W3099252273
- Cited by
- 460
- References
- 103
- Citations by year
- 2026: 58 · 2025: 93 · 2024: 104 · 2023: 92 · 2022: 84 · 2021: 27
- FWCI
- 4.48
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Molecules (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- The Arkansas Department of Education (ADE) (2019SURF)
- Federal TRIO Programs, United States Department of Education (McNair (LP))
- NSF (1946391)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Physical Sciences › Materials Science › Materials Chemistry › Machine Learning in Materials Science
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- Keywords
- machine learning in drug discovery, deep learning, drug target identification, virtual screening, lead compound identification, high-throughput screening, big data, drug candidate design
- MeSH terms
- Machine Learning, Deep Learning, Algorithms, Bayes Theorem, Humans, Monte Carlo Method, Software, Reproducibility of Results, Databases, Factual, Computational Biology, Internet, Drug Discovery, Support Vector Machine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Machine Learning Methods in Drug Discovery. https://app.cochat.ai/papers/10.3390/molecules25225277
- The paper
- Patel, L., Shukla, T., Huang, X., Ussery, D. W., & Wang, S. (2020). Machine Learning Methods in Drug Discovery. Molecules. https://doi.org/10.3390/molecules25225277
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.